Skip to content
PILLARS
Home
Bills
Recent BillsThe latest bills in Congress, in plain EnglishTrending BillsThe PILLARS Top 10 this week
Politicians
PoliticiansCongress, the White House and your repsPresidential ActionsOrders, memos and proclamationsExecutive BranchThe President, Vice President and Cabinet
Elections
Actions
More
Our SourcesWhere every number comes fromApp DetailsOur mission and the team behind itFeedbackTell us what is wrong or missingDownload the AppPILLARS for iPhone and Android
HomeRecent BillsActionsMore
ExploreElectionsPresidential ActionsPoliticiansTrending Bills
WatchlistSettingsProfile
HomeRecent BillsActionsMore
PILLARS

The bills, politicians, and elections that shape your life, in plain English.

Get the App
Our Receipts
Sources & MethodologyApp DetailsSend Feedback
The Legal Stuff
Privacy PolicyTerms of ServiceContact Us
Find Us On
© 2026 Political Pillars Inc.Simplifying politics
HR 5526
Recent Bills/HR 5526

Biosimilar Red Tape Elimination Act

IntroducedSeptember 19, 2025
In Committee1 year ago
Intro
House
Senate
Pres
In the House Energy and Commerce Committee.
The committee decides whether it goes to the full House. Most bills stay in committee.
Why This Matters

This bill revises federal requirements so that biosimilar biological products are automatically deemed interchangeable with their original reference products. It establishes a 60-day transition period and directs the Food and Drug Administration to update related guidance.

Who this affects
Manufacturers of biosimilars · FDA · Patients using biologics
What this bill changes
  1. 1Changes the law so a biosimilar biological product is automatically considered interchangeable with its reference product without a separate application.
  2. 2Sets a transition date 60 days after enactment when biosimilars licensed before then become interchangeable, unless another product’s exclusivity period is in effect.
  3. 3Deems biosimilars licensed on or after the transition date interchangeable upon licensure, unless blocked by an existing exclusivity period on the same reference product.

How would you vote?

Go deeper

Read full document

Last changed 1 day ago · checked hourly

Bill Progress1 of 4
A bill has to pass the House and Senate, then go to the President.
Intro
House
Senate
Pres
IntroducedCurrentSep 19, 2025

In the House Energy and Commerce Committee.

The committee decides whether it goes to the full House. Most bills stay in committee.

Sponsors
See all 11 sponsors
House
Senate
President

The President

Donald Trump
President
Not Sent Yet
Related Bills
Related bill
House Bill · HR 10857
1 of 4 · In Committee
Faster Clinical Trials Act
Similar bill
House Bill · HR 2821
3 of 4 · In the Senate
Updates Testing Rules for New Drugs
FDA Modernization Act 3.0
Healthcare
Similar bill
Senate Bill · S 1414
1 of 4 · Introduced
Simplifies Approval for Biosimilar Drugs
Expedited Access to Biosimilars Act
Healthcare